These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 38921017)
1. Drug-Resistance Biomarkers in Patient-Derived Colorectal Cancer Organoid and Fibroblast Co-Culture System. Ryu KB; Seo JA; Lee K; Choi J; Yoo G; Ha JH; Ahn MR Curr Issues Mol Biol; 2024 Jun; 46(6):5794-5811. PubMed ID: 38921017 [TBL] [Abstract][Full Text] [Related]
2. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture. Usui T; Sakurai M; Umata K; Elbadawy M; Ohama T; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K; Kaneda M; Sasaki K Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642386 [TBL] [Abstract][Full Text] [Related]
3. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. Schuth S; Le Blanc S; Krieger TG; Jabs J; Schenk M; Giese NA; Büchler MW; Eils R; Conrad C; Strobel O J Exp Clin Cancer Res; 2022 Oct; 41(1):312. PubMed ID: 36273171 [TBL] [Abstract][Full Text] [Related]
4. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model. Atanasova VS; de Jesus Cardona C; Hejret V; Tiefenbacher A; Mair T; Tran L; Pfneissl J; Draganić K; Binder C; Kabiljo J; Clement J; Woeran K; Neudert B; Wohlhaupter S; Haase A; Domazet S; Hengstschläger M; Mitterhauser M; Müllauer L; Tichý B; Bergmann M; Schweikert G; Hartl M; Dolznig H; Egger G Cell Mol Gastroenterol Hepatol; 2023; 15(6):1391-1419. PubMed ID: 36868311 [TBL] [Abstract][Full Text] [Related]
5. Hydrogel-based colorectal cancer organoid co-culture models. Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439 [TBL] [Abstract][Full Text] [Related]
6. Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance. Tung KL; Chen KY; Negrete M; Chen T; Safi A; Aljamal AA; Song L; Crawford GE; Ding S; Hsu DS; Shen X Genes Dis; 2021 Mar; 8(2):203-214. PubMed ID: 33997167 [TBL] [Abstract][Full Text] [Related]
7. Dickkopf 1 is expressed in normal fibroblasts during early stages of colorectal tumorigenesis. Inomata Y; Kuroha M; Shimoyama Y; Naito T; Moroi R; Shiga H; Kakuta Y; Karasawa H; Onuma S; Kinouchi Y; Masamune A Cancer Med; 2024 Jan; 13(2):e6992. PubMed ID: 38334454 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment. Usui T; Sakurai M; Enjoji S; Kawasaki H; Umata K; Ohama T; Fujiwara N; Yabe R; Tsuji S; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K Stem Cells Int; 2016; 2016():7053872. PubMed ID: 28119740 [TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance. Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015 [TBL] [Abstract][Full Text] [Related]
10. Whole-mount staining of mouse colorectal cancer organoids and fibroblast-organoid co-cultures. Martinez-Ordoñez A; Cid-Diaz T; Duran A; Han Q; Moscat J; Diaz-Meco MT STAR Protoc; 2023 Apr; 4(2):102243. PubMed ID: 37083323 [TBL] [Abstract][Full Text] [Related]
11. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer. Strating E; Verhagen MP; Wensink E; Dünnebach E; Wijler L; Aranguren I; De la Cruz AS; Peters NA; Hageman JH; van der Net MMC; van Schelven S; Laoukili J; Fodde R; Roodhart J; Nierkens S; Snippert H; Gloerich M; Rinkes IB; Elias SG; Kranenburg O Front Immunol; 2023; 14():1053920. PubMed ID: 37261365 [TBL] [Abstract][Full Text] [Related]
12. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. Li J; Liu J; Xia W; Yang H; Sha W; Chen H Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190 [TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268 [TBL] [Abstract][Full Text] [Related]
14. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Subtil B; Iyer KK; Poel D; Bakkerus L; Gorris MAJ; Escalona JC; van den Dries K; Cambi A; Verheul HMW; de Vries IJM; Tauriello DVF Front Immunol; 2023; 14():1105244. PubMed ID: 36761758 [TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Zhao Y; Li ZX; Zhu YJ; Fu J; Zhao XF; Zhang YN; Wang S; Wu JM; Wang KT; Wu R; Sui CJ; Shen SY; Wu X; Wang HY; Gao D; Chen L Adv Sci (Weinh); 2021 Jun; 8(11):e2003897. PubMed ID: 34105295 [TBL] [Abstract][Full Text] [Related]
17. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636 [TBL] [Abstract][Full Text] [Related]
18. Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells. Nakamura H; Sugano M; Miyashita T; Hashimoto H; Ochiai A; Suzuki K; Tsuboi M; Ishii G Lung Cancer; 2019 Aug; 134():100-107. PubMed ID: 31319967 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer. Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748 [TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation. Yadav VK; Huang YJ; George TA; Wei PL; Sumitra MR; Ho CL; Chang TH; Wu ATH; Huang HS Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]